Evidence map›Paper›PMID 31623764›Full record

Trial reportJournal of the American College of Cardiology2019

Guiding Therapy by Coronary CT Angiography Improves Outcomes in Patients With Stable Chest Pain.

Philip D Adamson, Michelle C Williams, Marc R Dweck, Nicholas L Mills, Nicholas A Boon, Marwa Daghem, Rong Bing, Alastair J Moss, Kenneth Mangion, Marcus Flather and 14 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American College of Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01149590 (Role of Multidetector Computed Tomography in the Diagnosis and Management of Patients Attending a Rapid Access Chest Pain Clinic), which is not on this map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01149590 nacompletednot on this map

Role of Multidetector Computed Tomography in the Diagnosis and Management of Patients Attending a Rapid Access Chest Pain Clinic

TypeinterventionalSponsorUniversity of EdinburghRan2010 to 2015Enrolled4,138ConditionsAngina Pectoris, Coronary Heart DiseaseArmsComputer Tomography Angiography
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Trial
  7. Repositioning of exercise treadmill testing in contemporary chest pain management.The international journal of cardiovascular imaging · 2026
    Review
  8. CAPIRE score predicts long-term major cardiac events.The international journal of cardiovascular imaging · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. The role of cardiac imaging in the post-ISCHEMIA world.The British journal of radiology · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Philip D AdamsonBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Christchurch Heart Institute, University of Otago, Christchurch, New Zealand. Electronic address: philip.adamson@cdhb.health.nz.
Michelle C WilliamsBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Marc R DweckBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Nicholas L MillsBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Nicholas A BoonBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Marwa DaghemBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Rong BingBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Alastair J MossBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Kenneth MangionInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Marcus FlatherNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
John ForbesHealth Research Institute, University of Limerick, Limerick, Ireland.
Amanda HunterBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
John NorrieEdinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, United Kingdom.
Anoop S V ShahBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Adam D TimmisWilliam Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Edwin J R van BeekEdinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Amir A AhmadiIchan School of Medicine and Mount Sinai Hospital, Mount Sinai Heart, New York, New York; St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Jonathon LeipsicSt. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Jagat NarulaIchan School of Medicine and Mount Sinai Hospital, Mount Sinai Heart, New York, New York.
David E NewbyBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute University of Edinburgh, Edinburgh, United Kingdom.
Giles RoditiInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
David A McAllisterInstitute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Colin BerryInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
SCOT-HEART Investigators

Funding

British Heart Foundation CH/09/002/26360British Heart Foundation FS/14/78/31020British Heart Foundation FS/16/14/32023British Heart Foundation RG/16/10/32375Chief Scientist Office PCL/17/04Medical Research Council G0701127Wellcome Trust
6 · The paper itself

Abstract

backgroundWithin the SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) trial of patients with stable chest pain, the use of coronary computed tomography angiography (CTA) reduced the rate of death from coronary heart disease or nonfatal myocardial infarction (primary endpoint).

objectivesThis study sought to assess the consistency and mechanisms of the 5-year reduction in this endpoint.

methodsIn this open-label trial, 4,146 participants were randomized to standard care alone or standard care plus coronary CTA. This study explored the primary endpoint by symptoms, diagnosis, coronary revascularizations, and preventative therapies.

resultsEvent reductions were consistent across symptom and risk categories (p = NS for interactions). In patients who were not diagnosed with angina due to coronary heart disease, coronary CTA was associated with a lower primary endpoint incidence rate (0.23; 95% confidence interval [CI]: 0.13 to 0.35 vs. 0.59; 95% CI: 0.42 to 0.80 per 100 patient-years; p < 0.001). In those who had undergone coronary CTA, rates of coronary revascularization were higher in the first year (hazard ratio [HR]: 1.21; 95% CI: 1.01 to 1.46; p = 0.042) but lower beyond 1 year (HR: 0.59; 95% CI: 0.38 to 0.90; p = 0.015). Patients assigned to coronary CTA had higher rates of preventative therapies throughout follow-up (p < 0.001 for all), with rates highest in those with CT-defined coronary artery disease. Modeling studies demonstrated the plausibility of the observed effect size.

conclusionsThe beneficial effect of coronary CTA on outcomes is consistent across subgroups with plausible underlying mechanisms. Coronary CTA improves coronary heart disease outcomes by enabling better targeting of preventative treatments to those with coronary artery disease. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590).

Indexed as

Computed Tomography AngiographyCoronary AngiographyAgedChest PainCoronary DiseaseElectrocardiographyFemaleFollow-Up StudiesHumansMaleMiddle AgedMyocardial InfarctionMyocardial RevascularizationPrognosisRisk AssessmentTreatment Outcomeangina pectoriscomputed tomographycoronary heart disease

Identifiers

PMID31623764
PMCPMC6899446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.